|
Originally published In Press as doi:10.1194/jlr.D500040-JLR200 on December 21, 2005
Journal of Lipid Research, Vol. 47, 673-676, March 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology
Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine
Mohammad Reza Hojjati and
Xian-Cheng Jiang1
Department of Anatomy and Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY 11203
Published, JLR Papers in Press, December 21, 2005.
1 To whom correspondence should be addressed. e-mail: xjiang{at}downstate.edu
Sphingomyelin (SM) and phosphatidylcholine (PC) are two major phospholipids on plasma lipoproteins. Their concentration is classically measured by lipid extraction, thin-layer chromatography, and phosphate determination on separated SM or PC spots. Here, we describe two rapid, specific, and sensitive enzymatic measurements for both phospholipids. Plasma was incubated with bacterial sphingomyelinase (for SM measurement) or bacterial PC-specific phospholipase D (for PC measurement), alkaline phosphatase, choline oxidase, peroxidase, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline, and 4-aminoantipyrine for 45 min. A blue dye, with an optimal absorption at 595 nm, was generated. PC levels did not influence SM measurement and vice versa. The linear range for the SM measurement was 0.55 µg, and that for PC was 2.520 µg. The mean percentage recovery was 98.0 ± 5.2% for SM and 96.6 ± 3.8% for PC. The interassay coefficient of variation of the assay was 1.7 ± 0.05% for SM and 3.1 ± 0.13% for PC. These two new methods are amenable to automation and can be adapted for large-scale, high-throughput assays.
Supplementary key words phospholipid measurement large-scale and high-throughput assays enzymatic measurements Abbreviations: DAOS, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline; PC, phosphatidylcholine; SM, sphingomyelin; SMase, sphingomyelinase

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Hamai, F. Keyserman, L. M. Quittell, and T. S. Worgall
Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling
J. Lipid Res.,
June 1, 2009;
50(6):
1101 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, H. Zhang, Z. Li, T. K. Hailemariam, M. Chakraborty, K. Jiang, D. Qiu, H. H. Bui, D. A. Peake, M.-S. Kuo, et al.
Sphingomyelin Synthase 2 Is One of the Determinants for Plasma and Liver Sphingomyelin Levels in Mice
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2009;
29(6):
850 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-S. Park, Y. Hu, H.-L. Noh, K. Drosatos, K. Okajima, J. Buchanan, J. Tuinei, S. Homma, X.-C. Jiang, E. D. Abel, et al.
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
J. Lipid Res.,
October 1, 2008;
49(10):
2101 - 2112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Glaros, W. S. Kim, K.-A. Rye, J. A. Shayman, and B. Garner
Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice
J. Lipid Res.,
August 1, 2008;
49(8):
1677 - 1681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Glaros, W. S. Kim, C. M. Quinn, W. Jessup, K.-A. Rye, and B. Garner
Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice
J. Lipid Res.,
February 1, 2008;
49(2):
324 - 331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ding, Z. Li, T. Hailemariam, S. Mukherjee, F. R. Maxfield, M.-P. Wu, and X.-C. Jiang
SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis
J. Lipid Res.,
February 1, 2008;
49(2):
376 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Sano, A. Kobayashi, K. Nagao, K. Kumagai, N. Kioka, K. Hanada, K. Ueda, and M. Matsuo
Sphingomyelin-dependence of cholesterol efflux mediated by ABCG1
J. Lipid Res.,
November 1, 2007;
48(11):
2377 - 2384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nagao, K. Takahashi, K. Hanada, N. Kioka, M. Matsuo, and K. Ueda
Enhanced ApoA-I-dependent Cholesterol Efflux by ABCA1 from Sphingomyelin-deficient Chinese Hamster Ovary Cells
J. Biol. Chem.,
May 18, 2007;
282(20):
14868 - 14874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yvan-Charvet, F. Matsuura, N. Wang, M. J. Bamberger, T. Nguyen, F. Rinninger, X.-C. Jiang, C. L. Shear, and A. R. Tall
Inhibition of Cholesteryl Ester Transfer Protein by Torcetrapib Modestly Increases Macrophage Cholesterol Efflux to HDL
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2007;
27(5):
1132 - 1138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dong, J. Liu, B. Lou, Z. Li, X. Ye, M. Wu, and X.-C. Jiang
Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice
J. Lipid Res.,
June 1, 2006;
47(6):
1307 - 1314.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|